Sales and Marketing

Showing 15 posts of 11527 posts found.

Campaigners urge for HPV vaccine to be extended to boys

September 22, 2014 Manufacturing and Production, Sales and Marketing HPV, Vaccine, boys, girls, human papilloma virus, rsph

Public health experts are meeting today to discuss whether boys as well as girls should be offered the HPV jab. …

Merck KGaA pays out $17 billion for Sigma-Aldrich

September 22, 2014 Manufacturing and Production, Sales and Marketing Millipore, Serono, Sigma-Aldrich, buyout, marck kgaa, sigma aldrich

Merck KGaA has swooped in and bought US-based Sigma-Aldrich in a deal worth $17 billion (€13.1 billion). The acquisition will …

Half of cancers diagnosed at late stage

September 22, 2014 Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, oncology

A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an …

Gilead’s blood cancer pill approved in Europe

September 22, 2014 Sales and Marketing CLL, Gilead, blood cancer, fl, idelalisib, oncology, zydelig

Gilead has gained European Commission approval for its new blood cancer pill Zydelig (idelalisib) as it looks to expand further …

IXICO hires chief financial officer

September 22, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

UK-based medical tech business IXICO has appointed Susan Lowther to its board as a chief financial officer.  Lowther was previously …

Pharma and Twitter: a happy marriage or time for a divorce?

September 22, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Facebook, PMCPA, Twitter, digital, pharma, social media

There has been a phenomenal rise in the use and scale of social media over the past decade, from the …

GSK fined, executives face jail sentence in Chinese bribery case

September 19, 2014 Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery, sex tape

China has fined Britain’s largest pharma firm GlaxoSmithKline $490 million (£297m) for corruption after a year-long investigation into claims it …

Boehringer pays $600m for cancer vaccine deal

September 19, 2014 Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1

Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …

‘Angelina effect’ sees BRCA tests soar in UK

September 19, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, angelina jolie, brac1, brad, breast, mastectomy

Referrals for testing for breast cancer risk more than doubled across the UK, after Oscar-winning American actress Angelina Jolie announced …

Changes at the top for Merck KGaA

September 19, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Belén Garijo, Merck KGaA, Stefan Oschmann

German chemical and pharma giant Merck KGaA has promoted Stefan Oschmann to the position of deputy chief executive and vice …

Scotland votes no for independence

September 19, 2014 Medical Communications, Research and Development, Sales and Marketing NHS, Scotland

The United Kingdom remains united today as Scotland  narrowly voted against breaking up the 307-year-old union. The ‘No, Better Together’ …

Astellas appoints comms head from Baxter

September 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris

Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …

Apple’s HealthKit plagued by bugs and delay

September 18, 2014 Medical Communications, Sales and Marketing Apple, Samsung, digital, google, health kit, ios8, wearables

Apple’s new mobile software iOS8 was launched around the world yesterday but the eagerly anticipated centrepiece HealthKit app was conspicuous …

GSK melanoma drug sees quick NICE nod

September 18, 2014 Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer

NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …

NICE reform put on hold – for now

September 17, 2014 Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba

The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …
The Gateway to Local Adoption Series

Latest content